{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:19:44Z","timestamp":1794431984649,"version":"4.9.1"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LTGD23C040008"],"award-info":[{"award-number":["LTGD23C040008"]}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["LBY23H200006"],"award-info":[{"award-number":["LBY23H200006"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ningbo Top Medical and Health Research Program","award":["2023020612"],"award-info":[{"award-number":["2023020612"]}]},{"name":"Ningbo Public Welfare Project","award":["2023-S013"],"award-info":[{"award-number":["2023-S013"]}]},{"name":"Talent Initiation Program of the High-Level University Development Project at Guangzhou Medical University","award":["06-445-1211"],"award-info":[{"award-number":["06-445-1211"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07407-0","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:46:55Z","timestamp":1764686815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Advances in capsule-based fecal microbiota transplantation: clinical applications and innovations"],"prefix":"10.1186","volume":"23","author":[{"given":"He","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-2153","authenticated-orcid":false,"given":"Yuping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"7407_CR1","doi-asserted-by":"publisher","first-page":"2412376","DOI":"10.1080\/19490976.2024.2412376","volume":"16","author":"DY Kim","year":"2024","unstructured":"Kim DY, Lee SY, Lee JY, Whon TW, Lee JY, Jeon CO, Bae JW. Gut Microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products. Gut Microbes. 2024;16:2412376.","journal-title":"Gut Microbes"},{"key":"7407_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41378-024-00743-z","volume":"10","author":"A Gholami","year":"2024","unstructured":"Gholami A, Mohkam M, Soleimanian S, Sadraeian M, Lauto A. Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy. Microsyst Nanoeng. 2024;10:113.","journal-title":"Microsyst Nanoeng"},{"key":"7407_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3949\/ccjm.92a.24107","volume":"92","author":"M Cymbal","year":"2025","unstructured":"Cymbal M, Chatterjee A, Baggott B. Fecal microbiota transplantation: current evidence and future directions. Cleve Clin J Med. 2025;92:421\u20138.","journal-title":"Cleve Clin J Med"},{"key":"7407_CR4","first-page":"854","volume":"44","author":"B Eiseman","year":"1958","unstructured":"Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous Enterocolitis. Surgery. 1958;44:854\u20139.","journal-title":"Surgery"},{"key":"7407_CR5","doi-asserted-by":"crossref","unstructured":"Vitiello A, Sabbatucci M, Zovi A, Salzano A, Ponzo A, Boccellino M. Advances in therapeutic strategies for the management of clostridioides difficile infection. J Clin Med. 2024;13.","DOI":"10.3390\/jcm13051331"},{"key":"7407_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cmi.2023.12.007","volume":"30","author":"N Benech","year":"2024","unstructured":"Benech N, Barbut F, Fitzpatrick F, Krutova M, Davies K, Druart C, Cordaillat-Simmons M, Heritage J, Guery B, Kuijper E. Update on microbiota-derived therapies for recurrent clostridioides difficile infections. Clin Microbiol Infect. 2024;30:462\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"7407_CR7","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1177\/2050640618780762","volume":"6","author":"G Ianiro","year":"2018","unstructured":"Ianiro G, Maida M, Burisch J, Simonelli C, Hold G, Ventimiglia M, Gasbarrini A, Cammarota G. Efficacy of different faecal microbiota transplantation protocols for clostridium difficile infection: A systematic review and meta-analysis. United Eur Gastroenterol J. 2018;6:1232\u201344.","journal-title":"United Eur Gastroenterol J"},{"key":"7407_CR8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12967-025-06797-5","volume":"23","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan H, Nouri S, Maleknia M, Aghaei M. The Microbiome in graft-versus-host disease: a Tale of two ecosystems. J Transl Med. 2025;23:832.","journal-title":"J Transl Med"},{"key":"7407_CR9","doi-asserted-by":"publisher","first-page":"113591","DOI":"10.1016\/j.celrep.2023.113591","volume":"43","author":"CJ Yang","year":"2024","unstructured":"Yang CJ, Chang HC, Sung PC, Ge MC, Tang HY, Cheng ML, Cheng HT, Chou HH, Lin CY, Lin WR, et al. Oral fecal transplantation enriches lachnospiraceae and butyrate to mitigate acute liver injury. Cell Rep. 2024;43:113591.","journal-title":"Cell Rep"},{"key":"7407_CR10","doi-asserted-by":"publisher","first-page":"110803","DOI":"10.1016\/j.diabres.2023.110803","volume":"202","author":"L Zecheng","year":"2023","unstructured":"Zecheng L, Donghai L, Runchuan G, Yuan Q, Qi J, Yijia Z, Shuaman R, Xiaoqi L, Yi W, Ni M, et al. Fecal microbiota transplantation in obesity metabolism: A meta analysis and systematic review. Diabetes Res Clin Pract. 2023;202:110803.","journal-title":"Diabetes Res Clin Pract"},{"key":"7407_CR11","doi-asserted-by":"publisher","first-page":"103062","DOI":"10.1016\/j.jaut.2023.103062","volume":"141","author":"R Wu","year":"2023","unstructured":"Wu R, Xiong R, Li Y, Chen J, Yan R. Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation. J Autoimmun. 2023;141:103062.","journal-title":"J Autoimmun"},{"key":"7407_CR12","doi-asserted-by":"publisher","first-page":"759435","DOI":"10.3389\/fcimb.2021.759435","volume":"11","author":"N Li","year":"2021","unstructured":"Li N, Chen H, Cheng Y, Xu F, Ruan G, Ying S, Tang W, Chen L, Chen M, Lv L, et al. Fecal microbiota transplantation relieves Gastrointestinal and autism symptoms by improving the gut microbiota in an Open-Label study. Front Cell Infect Microbiol. 2021;11:759435.","journal-title":"Front Cell Infect Microbiol"},{"key":"7407_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13756-022-01064-4","volume":"11","author":"J Hyun","year":"2022","unstructured":"Hyun J, Lee SK, Cheon JH, Yong DE, Koh H, Kang YK, Kim MH, Sohn Y, Cho Y, Baek YJ, et al. Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms. Antimicrob Resist Infect Control. 2022;11:20.","journal-title":"Antimicrob Resist Infect Control"},{"key":"7407_CR14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s13238-018-0541-8","volume":"9","author":"F Zhang","year":"2018","unstructured":"Zhang F, Cui B, He X, Nie Y, Wu K, Fan D. Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell. 2018;9:462\u201373.","journal-title":"Protein Cell"},{"key":"7407_CR15","doi-asserted-by":"publisher","first-page":"657320","DOI":"10.3389\/fcimb.2021.657320","volume":"11","author":"A Varga","year":"2021","unstructured":"Varga A, Kocsis B, Sipos D, K\u00e1sa P, Vigv\u00e1ri S, P\u00e1l S, Dembrovszky F, Farkas K, P\u00e9terfi Z. How to apply FMT more Effectively, conveniently and Flexible - A comparison of FMT methods. Front Cell Infect Microbiol. 2021;11:657320.","journal-title":"Front Cell Infect Microbiol"},{"key":"7407_CR16","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ajg.2017.6","volume":"112","author":"C Staley","year":"2017","unstructured":"Staley C, Hamilton MJ, Vaughn BP, Graiziger CT, Newman KM, Kabage AJ, Sadowsky MJ, Khoruts A. Successful resolution of recurrent clostridium difficile infection using Freeze-Dried, encapsulated fecal Microbiota; pragmatic cohort study. Am J Gastroenterol. 2017;112:940\u20137.","journal-title":"Am J Gastroenterol"},{"key":"7407_CR17","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/jama.2017.17077","volume":"318","author":"D Kao","year":"2017","unstructured":"Kao D, Roach B, Silva M, Beck P, Rioux K, Kaplan GG, Chang HJ, Coward S, Goodman KJ, Xu H, et al. Effect of oral Capsule- vs Colonoscopy-Delivered fecal microbiota transplantation on recurrent clostridium difficile infection: A randomized clinical trial. JAMA. 2017;318:1985\u201393.","journal-title":"JAMA"},{"key":"7407_CR18","doi-asserted-by":"crossref","unstructured":"Verdier C, Denis S, Gasc C, Boucinha L, Uriot O, Delmas D, Dore J, Le Camus C, Schwintner C, Blanquet-Diot S. An oral FMT capsule as efficient as an enema for microbiota reconstruction following disruption by Antibiotics, as assessed in an in vitro human gut model. Microorganisms. 2021:9.","DOI":"10.3390\/microorganisms9020358"},{"key":"7407_CR19","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10620-019-05821-1","volume":"65","author":"Y Luo","year":"2020","unstructured":"Luo Y, Lucas AL, Grinspan AM. Fecal transplants by colonoscopy and capsules are Cost-Effective strategies for treating recurrent clostridioides difficile infection. Dig Dis Sci. 2020;65:1125\u201333.","journal-title":"Dig Dis Sci"},{"key":"7407_CR20","doi-asserted-by":"publisher","first-page":"940","DOI":"10.7326\/ANNALS-24-03285","volume":"178","author":"FE Juul","year":"2025","unstructured":"Juul FE, Bretthauer M, Johnsen PH, Samy F, Tonby K, Berdal JE, Hoff DAL, Ofstad EH, Abraham A, Seip B, et al. Fecal microbiota transplantation versus Vancomycin for primary clostridioides difficile infection: A randomized controlled trial. Ann Intern Med. 2025;178:940\u20137.","journal-title":"Ann Intern Med"},{"key":"7407_CR21","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/apt.17975","volume":"59","author":"LM Clarke","year":"2024","unstructured":"Clarke LM, Allegretti JR. Review article: the epidemiology and management of clostridioides difficile infection-A clinical update. Aliment Pharmacol Ther. 2024;59:1335\u201349.","journal-title":"Aliment Pharmacol Ther"},{"key":"7407_CR22","doi-asserted-by":"publisher","first-page":"2223345","DOI":"10.1080\/19490976.2023.2223345","volume":"15","author":"AJ Gonzales-Luna","year":"2023","unstructured":"Gonzales-Luna AJ, Carlson TJ, Garey KW. Gut microbiota changes associated with clostridioides difficile infection and its various treatment strategies. Gut Microbes. 2023;15:2223345.","journal-title":"Gut Microbes"},{"key":"7407_CR23","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.14309\/ajg.0000000000002770","volume":"119","author":"JR Allegretti","year":"2024","unstructured":"Allegretti JR, Axelrad J, Dalal RS, Kelly CR, Grinspan A, Fischer M. Outcomes after fecal microbiota transplantation in combination with bezlotoxumab for inflammatory bowel disease and recurrent clostridioides difficile infection. Am J Gastroenterol. 2024;119:1433\u20136.","journal-title":"Am J Gastroenterol"},{"key":"7407_CR24","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S2468-1253(22)00276-X","volume":"7","author":"SMD Baunwall","year":"2022","unstructured":"Baunwall SMD, Andreasen SE, Hansen MM, Kelsen J, H\u00f8yer KL, R\u00e5g\u00e5rd N, Eriksen LL, St\u00f8y S, Rubak T, Damsgaard EMS, et al. Faecal microbiota transplantation for first or second clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022;7:1083\u201391.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7407_CR25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/apt.16309","volume":"53","author":"AA Rode","year":"2021","unstructured":"Rode AA, Chehri M, Krogsgaard LR, Heno KK, Svendsen AT, Ribberholt I, Helms M, Engberg J, Sch\u00f8nning K, Tvede M, et al. Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus Vancomycin for recurrent clostridioides difficile infections. Aliment Pharmacol Ther. 2021;53:999\u20131009.","journal-title":"Aliment Pharmacol Ther"},{"key":"7407_CR26","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1001\/jama.2014.13875","volume":"312","author":"I Youngster","year":"2014","unstructured":"Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing clostridium difficile infection. JAMA. 2014;312:1772\u20138.","journal-title":"JAMA"},{"key":"7407_CR27","doi-asserted-by":"publisher","first-page":"e0205064","DOI":"10.1371\/journal.pone.0205064","volume":"13","author":"ZD Jiang","year":"2018","unstructured":"Jiang ZD, Jenq RR, Ajami NJ, Petrosino JF, Alexander AA, Ke S, Iqbal T, DuPont AW, Muldrew K, Shi Y, et al. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent clostridium difficile infection: A randomized clinical trial. PLoS ONE. 2018;13:e0205064.","journal-title":"PLoS ONE"},{"key":"7407_CR28","doi-asserted-by":"crossref","unstructured":"Haifer C, Paramsothy S, Borody TJ, Clancy A, Leong RW, Kaakoush NO. Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection. mSystems 2021, 6.","DOI":"10.1128\/mSystems.00905-20"},{"key":"7407_CR29","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1038\/s41598-021-84152-6","volume":"11","author":"C Staley","year":"2021","unstructured":"Staley C, Halaweish H, Graiziger C, Hamilton MJ, Kabage AJ, Galdys AL, Vaughn BP, Vantanasiri K, Suryanarayanan R, Sadowsky MJ, Khoruts A. Lower endoscopic delivery of freeze-dried intestinal microbiota results in more rapid and efficient engraftment than oral administration. Sci Rep. 2021;11:4519.","journal-title":"Sci Rep"},{"key":"7407_CR30","doi-asserted-by":"publisher","first-page":"e0110825","DOI":"10.1128\/mbio.01108-25","volume":"16","author":"SA Millard","year":"2025","unstructured":"Millard SA, Vendrov KC, Young VB, Seekatz AM. Host origin of microbiota drives functional recovery and clostridioides difficile clearance in mice. mBio. 2025;16:e0110825.","journal-title":"mBio"},{"key":"7407_CR31","doi-asserted-by":"publisher","first-page":"2232137","DOI":"10.1080\/19490976.2023.2232137","volume":"15","author":"N Jain","year":"2023","unstructured":"Jain N, Umar TP, Fahner AF, Gibietis V. Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst\u2019s FDA approval and implications. Gut Microbes. 2023;15:2232137.","journal-title":"Gut Microbes"},{"key":"7407_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/cid\/ciae467","volume":"80","author":"DM Drekonja","year":"2025","unstructured":"Drekonja DM, Shaukat A, Huang Y, Zhang JH, Reinink AR, Nugent S, Dominitz JA, Davis-Karim A, Gerding DN, Kyriakides TC. A randomized controlled trial of efficacy and safety of fecal microbiota transplant for preventing recurrent clostridioides difficile infection. Clin Infect Dis. 2025;80:52\u201360.","journal-title":"Clin Infect Dis"},{"key":"7407_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40168-024-01825-w","volume":"12","author":"JM Brenchley","year":"2024","unstructured":"Brenchley JM, Serrano-Villar S. From dysbiosis to defense: Harnessing the gut Microbiome in HIV\/SIV therapy. Microbiome. 2024;12:113.","journal-title":"Microbiome"},{"key":"7407_CR34","doi-asserted-by":"publisher","first-page":"e1004543","DOI":"10.1371\/journal.ppat.1004543","volume":"10","author":"A Schuetz","year":"2014","unstructured":"Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, Estes JD, Sandler NG, Sukhumvittaya S, Marovich M, et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog. 2014;10:e1004543.","journal-title":"PLoS Pathog"},{"key":"7407_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531\u201364.","journal-title":"Annu Rev Immunol"},{"key":"7407_CR36","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.1073\/pnas.0909122107","volume":"107","author":"JL Round","year":"2010","unstructured":"Round JL, Mazmanian SK. Inducible Foxp3\u2009+\u2009regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107:12204\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7407_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12866-024-03335-z","volume":"24","author":"E Rubio Garcia","year":"2024","unstructured":"Rubio Garcia E, Casadell\u00e0 M, Parera M, Vila J, Paredes R, Noguera-Julian M. Gut resistome linked to sexual preference and HIV infection. BMC Microbiol. 2024;24:201.","journal-title":"BMC Microbiol"},{"key":"7407_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/QAD.0000000000000935","volume":"30","author":"L Yang","year":"2016","unstructured":"Yang L, Poles MA, Fisch GS, Ma Y, Nossa C, Phelan JA, Pei Z. HIV-induced immunosuppression is associated with colonization of the proximal gut by environmental bacteria. Aids. 2016;30:19\u201329.","journal-title":"Aids"},{"key":"7407_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/imm.12760","volume":"151","author":"JM Larsen","year":"2017","unstructured":"Larsen JM. The immune response to prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151:363\u201374.","journal-title":"Immunology"},{"key":"7407_CR40","doi-asserted-by":"publisher","first-page":"e0172738","DOI":"10.1371\/journal.pone.0172738","volume":"12","author":"F Jiang","year":"2017","unstructured":"Jiang F, Meng D, Weng M, Zhu W, Wu W, Kasper D, Walker WA. The symbiotic bacterial surface factor polysaccharide A on bacteroides fragilis inhibits IL-1\u03b2-induced inflammation in human fetal enterocytes via toll receptors 2 and 4. PLoS ONE. 2017;12:e0172738.","journal-title":"PLoS ONE"},{"key":"7407_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/mi.2015.33","volume":"9","author":"SM Dillon","year":"2016","unstructured":"Dillon SM, Lee EJ, Kotter CV, Austin GL, Gianella S, Siewe B, Smith DM, Landay AL, McManus MC, Robertson CE, et al. Gut dendritic cell activation links an altered colonic Microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection. Mucosal Immunol. 2016;9:24\u201337.","journal-title":"Mucosal Immunol"},{"key":"7407_CR42","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1097\/QAD.0b013e3283611816","volume":"27","author":"J P\u00e9rez-Santiago","year":"2013","unstructured":"P\u00e9rez-Santiago J, Gianella S, Massanella M, Spina CA, Karris MY, Var SR, Patel D, Jordan PS, Young JA, Little SJ, et al. Gut lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. Aids. 2013;27:1921\u201331.","journal-title":"Aids"},{"key":"7407_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/COH.0000000000000234","volume":"11","author":"AS Zevin","year":"2016","unstructured":"Zevin AS, McKinnon L, Burgener A, Klatt NR. Microbial translocation and Microbiome dysbiosis in HIV-associated immune activation. Curr Opin HIV AIDS. 2016;11:182\u201390.","journal-title":"Curr Opin HIV AIDS"},{"key":"7407_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s40168-024-01919-5","volume":"12","author":"C D\u00edaz-Garc\u00eda","year":"2024","unstructured":"D\u00edaz-Garc\u00eda C, Moreno E, Talavera-Rodr\u00edguez A, Mart\u00edn-Fern\u00e1ndez L, Gonz\u00e1lez-Bod\u00ed S, Mart\u00edn-Pedraza L, P\u00e9rez-Molina JA, Dronda F, Gosalbes MJ, Luna L, et al. Fecal microbiota transplantation alters the proteomic landscape of inflammation in HIV: identifying bacterial drivers. Microbiome. 2024;12:214.","journal-title":"Microbiome"},{"key":"7407_CR45","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41467-021-21472-1","volume":"12","author":"S Serrano-Villar","year":"2021","unstructured":"Serrano-Villar S, Talavera-Rodr\u00edguez A, Gosalbes MJ, Madrid N, P\u00e9rez-Molina JA, Elliott RJ, Navia B, Lanza VF, Vallejo A, Osman M, et al. Fecal microbiota transplantation in HIV: A pilot placebo-controlled study. Nat Commun. 2021;12:1139.","journal-title":"Nat Commun"},{"key":"7407_CR46","doi-asserted-by":"publisher","first-page":"364","DOI":"10.20411\/pai.v5i1.388","volume":"5","author":"NS Utay","year":"2020","unstructured":"Utay NS, Monczor AN, Somasunderam A, Lupo S, Jiang ZD, Alexander AS, Finkelman M, Vigil KJ, Lake JE, Hanson B, et al. Evaluation of six weekly oral fecal microbiota transplants in people with HIV. Pathog Immun. 2020;5:364\u201381.","journal-title":"Pathog Immun"},{"key":"7407_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13073-021-00869-z","volume":"13","author":"QR Ducarmon","year":"2021","unstructured":"Ducarmon QR, Terveer EM, Nooij S, Bloem MN, Vendrik KEW, Caljouw MAA, Sanders I, van Dorp SM, Wong MC, Zwittink RD, Kuijper EJ. Microbiota-associated risk factors for asymptomatic gut colonisation with multi-drug-resistant organisms in a Dutch nursing home. Genome Med. 2021;13:54.","journal-title":"Genome Med"},{"key":"7407_CR48","doi-asserted-by":"publisher","first-page":"e01361","DOI":"10.1128\/mBio.01361-14","volume":"5","author":"A Zaborin","year":"2014","unstructured":"Zaborin A, Smith D, Garfield K, Quensen J, Shakhsheer B, Kade M, Tirrell M, Tiedje J, Gilbert JA, Zaborina O, Alverdy JC. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. mBio. 2014;5:e01361\u201301314.","journal-title":"mBio"},{"key":"7407_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jhin.2022.11.007","volume":"131","author":"EH Lee","year":"2023","unstructured":"Lee EH, Lee SK, Cheon JH, Koh H, Lee JA, Kim CH, Kim JN, Lee KH, Lee SJ, Kim JH, et al. Comparing the efficacy of different methods of faecal microbiota transplantation via oral capsule, oesophagogastroduodenoscopy, colonoscopy, or gastric tube. J Hosp Infect. 2023;131:234\u201343.","journal-title":"J Hosp Infect"},{"key":"7407_CR50","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1093\/cid\/ciaa737","volume":"73","author":"H Bar-Yoseph","year":"2021","unstructured":"Bar-Yoseph H, Carasso S, Shklar S, Korytny A, Even Dar R, Daoud H, Nassar R, Maharshak N, Hussein K, Geffen Y, et al. Oral capsulized fecal microbiota transplantation for eradication of Carbapenemase-producing Enterobacteriaceae colonization with a metagenomic perspective. Clin Infect Dis. 2021;73:e166\u201375.","journal-title":"Clin Infect Dis"},{"key":"7407_CR51","doi-asserted-by":"crossref","unstructured":"Lopetuso LR, Deleu S, Godny L, Petito V, Puca P, Facciotti F, Sokol H, Ianiro G, Masucci L, Abreu M et al. The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut. 2023;72:1642\u20131650.","DOI":"10.1136\/gutjnl-2023-329948"},{"key":"7407_CR52","doi-asserted-by":"publisher","first-page":"e0047923","DOI":"10.1128\/msphere.00479-23","volume":"8","author":"H Kuang","year":"2023","unstructured":"Kuang H, Yang Y, Luo H, Lv X. The impact of three carbapenems at a single-day dose on intestinal colonization resistance against carbapenem-resistant Klebsiella pneumoniae. mSphere. 2023;8:e0047923.","journal-title":"mSphere"},{"key":"7407_CR53","doi-asserted-by":"crossref","unstructured":"Haneishi Y, Furuya Y, Hasegawa M, Picarelli A, Rossi M, Miyamoto J. Inflammatory bowel diseases and gut microbiota. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms24043817"},{"key":"7407_CR54","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41575-023-00871-3","volume":"21","author":"C Danne","year":"2024","unstructured":"Danne C, Skerniskyte J, Marteyn B, Sokol H. Neutrophils: from IBD to the gut microbiota. Nat Rev Gastroenterol Hepatol. 2024;21:184\u201397.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7407_CR55","first-page":"225","volume":"28","author":"[Consensus of Chinese experts on gut","year":"2025","unstructured":"[Consensus of Chinese experts on gut. Microbiota and fecal microbiota transplantation in inflammatory bowel disease (2025 edition)]. Zhonghua Wei Chang Wai Ke Za Zhi. 2025;28:225\u201335.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"7407_CR56","doi-asserted-by":"crossref","unstructured":"Lopetuso LR, Deleu S, Puca P, Abreu MT, Armuzzi A, Barbara G, Caprioli F, Chieng S, Costello SP, Damiani A et al. Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference. Inflamm Bowel Dis. 2025;31:2408\u20132419.","DOI":"10.1093\/ibd\/izaf013"},{"key":"7407_CR57","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12916-025-04353-y","volume":"23","author":"G Lu","year":"2025","unstructured":"Lu G, Zhang S, Wang R, Wu X, Chen Y, Wen Q, Cui B, Zhang F, Li P. Fecal microbiota transplantation improves bile acid malabsorption in patients with inflammatory bowel disease: results of microbiota and metabolites from two cohort studies. BMC Med. 2025;23:511.","journal-title":"BMC Med"},{"key":"7407_CR58","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","volume":"7","author":"C Haifer","year":"2022","unstructured":"Haifer C, Paramsothy S, Kaakoush NO, Saikal A, Ghaly S, Yang T, Luu LDW, Borody TJ, Leong RW. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022;7:141\u201351.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7407_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13063-022-06095-1","volume":"23","author":"A Stallmach","year":"2022","unstructured":"Stallmach A, Grunert P, Stallhofer J, L\u00f6ffler B, Baier M, R\u00f6del J, Kiehntopf M, Neugebauer S, Pieper DH, Junca H, et al. Transfer of frozen encapsulated multi-donor stool filtrate for active ulcerative colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Trials. 2022;23:173.","journal-title":"Trials"},{"key":"7407_CR60","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12967-024-05832-1","volume":"23","author":"B Zou","year":"2025","unstructured":"Zou B, Liu S, Dong C, Shen H, Lv Y, He J, Li X, Ruan M, Huang Z, Shu S. Fecal microbiota transplantation restores gut microbiota diversity in children with active crohn\u2019s disease: a prospective trial. J Transl Med. 2025;23:288.","journal-title":"J Transl Med"},{"key":"7407_CR61","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12876-021-01856-9","volume":"21","author":"JW Crothers","year":"2021","unstructured":"Crothers JW, Chu ND, Nguyen LTT, Phillips M, Collins C, Fortner K, Del Rio-Guerra R, Lavoie B, Callas P, Velez M, et al. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. BMC Gastroenterol. 2021;21:281.","journal-title":"BMC Gastroenterol"},{"key":"7407_CR62","doi-asserted-by":"publisher","first-page":"e030120","DOI":"10.1136\/bmjopen-2019-030120","volume":"9","author":"N Pai","year":"2019","unstructured":"Pai N, Popov J, Hill L, Hartung E. Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric crohn\u2019s disease population: pedicraft trial. BMJ Open. 2019;9:e030120.","journal-title":"BMJ Open"},{"key":"7407_CR63","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/jama.2020.22532","volume":"325","author":"M Camilleri","year":"2021","unstructured":"Camilleri M. Diagnosis and treatment of irritable bowel syndrome: A review. JAMA. 2021;325:865\u201377.","journal-title":"JAMA"},{"key":"7407_CR64","doi-asserted-by":"crossref","unstructured":"Napolitano M, Fasulo E, Ungaro F, Massimino L, Sinagra E, Danese S, Mandarino FV. Gut dysbiosis in irritable bowel syndrome: A narrative review on correlation with disease subtypes and novel therapeutic implications. Microorganisms. 2023:11.","DOI":"10.3390\/microorganisms11102369"},{"key":"7407_CR65","doi-asserted-by":"crossref","unstructured":"Di Rosa C, Altomare A, Terrigno V, Carbone F, Tack J, Cicala M, Guarino MPL. Constipation-Predominant irritable bowel syndrome (IBS-C): effects of different nutritional patterns on intestinal dysbiosis and symptoms. Nutrients. 2023:15.","DOI":"10.3390\/nu15071647"},{"key":"7407_CR66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41522-024-00549-x","volume":"10","author":"AK Hartikainen","year":"2024","unstructured":"Hartikainen AK, Jalanka J, Lahtinen P, Ponsero AJ, Mertsalmi T, Finnegan L, Crispie F, Cotter PD, Arkkila P, Satokari R. Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients. NPJ Biofilms Microbiomes. 2024;10:73.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"7407_CR67","doi-asserted-by":"crossref","unstructured":"Wu Y, Li Y, Zheng Q, Li L. The efficacy of Probiotics, Prebiotics, Synbiotics, and fecal microbiota transplantation in irritable bowel syndrome: A systematic review and network Meta-Analysis. Nutrients. 2024:16.","DOI":"10.3390\/nu16132114"},{"key":"7407_CR68","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","volume":"69","author":"M El-Salhy","year":"2020","unstructured":"El-Salhy M, Hatlebakk JG, Gilja OH, Br\u00e5then Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020;69:859\u201367.","journal-title":"Gut"},{"key":"7407_CR69","doi-asserted-by":"crossref","unstructured":"El-Salhy M, Hausken T, Hatlebakk JG. Increasing the dose and\/or repeating faecal microbiota transplantation (FMT) increases the response in patients with irritable bowel syndrome (IBS). Nutrients. 2019:11.","DOI":"10.3390\/nu11061415"},{"key":"7407_CR70","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1136\/gutjnl-2018-316434","volume":"67","author":"SI Halkj\u00e6r","year":"2018","unstructured":"Halkj\u00e6r SI, Christensen AH, Lo BZS, Browne PD, G\u00fcnther S, Hansen LH, Petersen AM. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut. 2018;67:2107\u201315.","journal-title":"Gut"},{"key":"7407_CR71","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S2468-1253(19)30198-0","volume":"4","author":"OC Aroniadis","year":"2019","unstructured":"Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, et al. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2019;4:675\u201385.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7407_CR72","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman DA, Hasler WL. Rome IV-Functional GI disorders: disorders of Gut-Brain interaction. Gastroenterology. 2016;150:1257\u201361.","journal-title":"Gastroenterology"},{"key":"7407_CR73","unstructured":"[Chinese surgical diagnosis and treatment consensus on slow transit constipation. (2023 edition)]. Zhonghua Wei Chang Wai Ke Za Zhi. 2023;26:1112\u20131121."},{"key":"7407_CR74","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1017\/S0007114522003853","volume":"130","author":"R Erhardt","year":"2023","unstructured":"Erhardt R, Harnett JE, Steels E, Steadman KJ. Functional constipation and the effect of prebiotics on the gut microbiota: a review. Br J Nutr. 2023;130:1015\u201323.","journal-title":"Br J Nutr"},{"key":"7407_CR75","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fnut.2018.00040","volume":"5","author":"MR Sanctuary","year":"2018","unstructured":"Sanctuary MR, Kain JN, Angkustsiri K, German JB. Dietary considerations in autism spectrum disorders: the potential role of protein digestion and microbial putrefaction in the Gut-Brain axis. Front Nutr. 2018;5:40.","journal-title":"Front Nutr"},{"key":"7407_CR76","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1038\/s41598-017-10663-w","volume":"7","author":"L Mancabelli","year":"2017","unstructured":"Mancabelli L, Milani C, Lugli GA, Turroni F, Mangifesta M, Viappiani A, Ticinesi A, Nouvenne A, Meschi T, van Sinderen D, Ventura M. Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses. Sci Rep. 2017;7:9879.","journal-title":"Sci Rep"},{"key":"7407_CR77","doi-asserted-by":"publisher","first-page":"e0006022","DOI":"10.1128\/cmr.00060-22","volume":"37","author":"A Yadegar","year":"2024","unstructured":"Yadegar A, Bar-Yoseph H, Monaghan TM, Pakpour S, Severino A, Kuijper EJ, Smits WK, Terveer EM, Neupane S, Nabavi-Rad A, et al. Fecal microbiota transplantation: current challenges and future landscapes. Clin Microbiol Rev. 2024;37:e0006022.","journal-title":"Clin Microbiol Rev"},{"key":"7407_CR78","first-page":"63","volume":"23","author":"HL Tian","year":"2020","unstructured":"Tian HL, Chen QY, Yang B, Ma CL, Lin ZL, Zhang XY, Zhou SL, Qin HL, Li N. [Effects of fecal microbiota transplantation in different routes on the clinical efficacy of slow transit constipation]. Zhonghua Wei Chang Wai Ke Za Zhi. 2020;23:63\u20138.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"7407_CR79","doi-asserted-by":"publisher","first-page":"e2306297","DOI":"10.1002\/advs.202306297","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Song F, Yang M, Chen C, Cui J, Xing M, Dai Y, Li M, Cao Y, Lu L, et al. Gastrointestinal dysmotility predisposes to colitis through regulation of gut microbial composition and Linoleic acid metabolism. Adv Sci (Weinh). 2024;11:e2306297.","journal-title":"Adv Sci (Weinh)"},{"key":"7407_CR80","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.3748\/wjg.v29.i22.3400","volume":"29","author":"I Efremova","year":"2023","unstructured":"Efremova I, Maslennikov R, Poluektova E, Vasilieva E, Zharikov Y, Suslov A, Letyagina Y, Kozlov E, Levshina A, Ivashkin V. Epidemiology of small intestinal bacterial overgrowth. World J Gastroenterol. 2023;29:3400\u201321.","journal-title":"World J Gastroenterol"},{"key":"7407_CR81","doi-asserted-by":"publisher","first-page":"710940","DOI":"10.3389\/fmicb.2021.710940","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Zhang R, Ma J, Tang S, Li Y, Li Y, Wan J. Mucosa-Associated microbial profile is altered in small intestinal bacterial overgrowth. Front Microbiol. 2021;12:710940.","journal-title":"Front Microbiol"},{"key":"7407_CR82","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12876-021-01630-x","volume":"21","author":"F Xu","year":"2021","unstructured":"Xu F, Li N, Wang C, Xing H, Chen D, Wei Y. Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study. BMC Gastroenterol. 2021;21:54.","journal-title":"BMC Gastroenterol"},{"key":"7407_CR83","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","volume":"9","author":"L Cui","year":"2024","unstructured":"Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, Wang Y, Tang Y, Xia M, Li B. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9:30.","journal-title":"Signal Transduct Target Ther"},{"key":"7407_CR84","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.biopsych.2023.08.020","volume":"95","author":"AJ McGuinness","year":"2024","unstructured":"McGuinness AJ, Loughman A, Foster JA, Jacka F. Mood disorders: the gut bacteriome and beyond. Biol Psychiatry. 2024;95:319\u201328.","journal-title":"Biol Psychiatry"},{"key":"7407_CR85","doi-asserted-by":"publisher","first-page":"105316","DOI":"10.1016\/j.neubiorev.2023.105316","volume":"153","author":"LM Keubler","year":"2023","unstructured":"Keubler LM, Talbot SR, Bleich A, Boyle EC. Systematic review and meta-analysis of the effect of fecal microbiota transplantation on behavior in animals. Neurosci Biobehav Rev. 2023;153:105316.","journal-title":"Neurosci Biobehav Rev"},{"key":"7407_CR86","doi-asserted-by":"publisher","first-page":"104527","DOI":"10.1016\/j.ebiom.2023.104527","volume":"90","author":"L Liu","year":"2023","unstructured":"Liu L, Wang H, Chen X, Zhang Y, Zhang H, Xie P. Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine. 2023;90:104527.","journal-title":"EBioMedicine"},{"key":"7407_CR87","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cmet.2024.03.010","volume":"36","author":"M Zhao","year":"2024","unstructured":"Zhao M, Ren Z, Zhao A, Tang Y, Kuang J, Li M, Chen T, Wang S, Wang J, Zhang H, et al. Gut bacteria-driven homovanillic acid alleviates depression by modulating synaptic integrity. Cell Metab. 2024;36:1000\u2013e10121006.","journal-title":"Cell Metab"},{"key":"7407_CR88","doi-asserted-by":"publisher","first-page":"e16908","DOI":"10.1016\/j.heliyon.2023.e16908","volume":"9","author":"MA Churchward","year":"2023","unstructured":"Churchward MA, Michaud ER, Mullish BH, Miguens Blanco J, Garcia Perez I, Marchesi JR, Xu H, Kao D, Todd KG. Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation. Heliyon. 2023;9:e16908.","journal-title":"Heliyon"},{"key":"7407_CR89","doi-asserted-by":"publisher","first-page":"11885","DOI":"10.1080\/21655979.2021.1999374","volume":"12","author":"Q Guo","year":"2021","unstructured":"Guo Q, Lin H, Chen P, Tan S, Wen Z, Lin L, He J, Wen J, Lu S. Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of Enterobacteria capsules. Bioengineered. 2021;12:11885\u201397.","journal-title":"Bioengineered"},{"key":"7407_CR90","doi-asserted-by":"publisher","first-page":"2434675","DOI":"10.1080\/19490976.2024.2434675","volume":"16","author":"Y Li","year":"2024","unstructured":"Li Y, Hu W, Lin B, Ma T, Zhang Z, Hu W, Zhou R, Kwok LY, Sun Z, Zhu C, Zhang H. Omic characterizing and targeting gut dysbiosis in children with autism spectrum disorder: symptom alleviation through combined probiotic and medium-carbohydrate diet intervention - a pilot study. Gut Microbes. 2024;16:2434675.","journal-title":"Gut Microbes"},{"key":"7407_CR91","doi-asserted-by":"publisher","first-page":"2418984","DOI":"10.1080\/19490976.2024.2418984","volume":"16","author":"Y Wan","year":"2024","unstructured":"Wan Y, Wong OWH, Tun HM, Su Q, Xu Z, Tang W, Ma SL, Chan S, Chan FKL, Ng SC. Fecal microbial marker panel for aiding diagnosis of autism spectrum disorders. Gut Microbes. 2024;16:2418984.","journal-title":"Gut Microbes"},{"key":"7407_CR92","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2022.23661","volume":"329","author":"T Hirota","year":"2023","unstructured":"Hirota T, King BH. Autism spectrum disorder: A review. JAMA. 2023;329:157\u201368.","journal-title":"JAMA"},{"key":"7407_CR93","doi-asserted-by":"publisher","first-page":"2499580","DOI":"10.1080\/19490976.2025.2499580","volume":"17","author":"E Takyi","year":"2025","unstructured":"Takyi E, Nirmalkar K, Adams J, Krajmalnik-Brown R. Interventions targeting the gut microbiota and their possible effect on Gastrointestinal and neurobehavioral symptoms in autism spectrum disorder. Gut Microbes. 2025;17:2499580.","journal-title":"Gut Microbes"},{"key":"7407_CR94","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","volume":"5","author":"DW Kang","year":"2017","unstructured":"Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, et al. Microbiota transfer therapy alters gut ecosystem and improves Gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5:10.","journal-title":"Microbiome"},{"key":"7407_CR95","doi-asserted-by":"publisher","first-page":"e074625","DOI":"10.1136\/bmjopen-2023-074625","volume":"14","author":"RY Tweedie-Cullen","year":"2024","unstructured":"Tweedie-Cullen RY, Leong K, Wilson BC, Derraik JGB, Albert BB, Monk R, Vatanen T, Creagh C, Depczynski M, Edwards T, et al. Protocol for the gut Bugs in autism trial: a double-blind randomised placebo-controlled trial of faecal Microbiome transfer for the treatment of Gastrointestinal symptoms in autistic adolescents and adults. BMJ Open. 2024;14:e074625.","journal-title":"BMJ Open"},{"key":"7407_CR96","doi-asserted-by":"publisher","first-page":"e1551","DOI":"10.1002\/wsbm.1551","volume":"14","author":"Y Cai","year":"2022","unstructured":"Cai Y, Chen L, Zhang S, Zeng L, Zeng G. The role of gut microbiota in infectious diseases. WIREs Mech Dis. 2022;14:e1551.","journal-title":"WIREs Mech Dis"},{"key":"7407_CR97","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg H, Adolph TE, Trauner M. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab. 2022;34:1700\u201318.","journal-title":"Cell Metab"},{"key":"7407_CR98","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jhep.2025.03.009","volume":"83","author":"DL Shawcross","year":"2025","unstructured":"Shawcross DL, Patel VC. FMT for hepatic encephalopathy? The THEMATIC trial aims to make it a \u2018no brainer\u2019. J Hepatol. 2025;83:11\u20134.","journal-title":"J Hepatol"},{"key":"7407_CR99","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jhep.2024.12.047","volume":"83","author":"JS Bajaj","year":"2025","unstructured":"Bajaj JS, Fagan A, Gavis EA, Sterling RK, Gallagher ML, Lee H, Matherly SC, Siddiqui MS, Bartels A, Mousel T, et al. Microbiota transplant for hepatic encephalopathy in cirrhosis: the THEMATIC trial. J Hepatol. 2025;83:81\u201391.","journal-title":"J Hepatol"},{"key":"7407_CR100","doi-asserted-by":"crossref","unstructured":"Ichim C, Boicean A, Todor SB, Anderco P, B\u00eerlu\u021biu V. Fecal microbiota transplantation in patients with Alcohol-Associated cirrhosis: A clinical trial. J Clin Med. 2025:14.","DOI":"10.3390\/jcm14175981"},{"key":"7407_CR101","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s12072-024-10647-9","volume":"18","author":"S Maharshi","year":"2024","unstructured":"Maharshi S, Sharma BC. Prophylaxis of hepatic encephalopathy: current and future drug targets. Hepatol Int. 2024;18:1096\u2013109.","journal-title":"Hepatol Int"},{"key":"7407_CR102","doi-asserted-by":"crossref","unstructured":"Hassouneh R, Bajaj JS. Gut microbiota modulation and fecal transplantation: an overview on innovative strategies for hepatic encephalopathy treatment. J Clin Med. 2021:10.","DOI":"10.3390\/jcm10020330"},{"key":"7407_CR103","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/hep.30690","volume":"70","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS, Salzman NH, Acharya C, Sterling RK, White MB, Gavis EA, Fagan A, Hayward M, Holtz ML, Matherly S, et al. Fecal microbial transplant capsules are safe in hepatic encephalopathy: A phase 1, Randomized, Placebo-Controlled trial. Hepatology. 2019;70:1690\u2013703.","journal-title":"Hepatology"},{"key":"7407_CR104","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Salzman N, Acharya C, Takei H, Kakiyama G, Fagan A, White MB, Gavis EA, Holtz ML, Hayward M et al. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis. JCI Insight. 2019;4.","DOI":"10.1172\/jci.insight.133410"},{"key":"7407_CR105","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","volume":"156","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS, Fagan A, Gavis EA, Kassam Z, Sikaroodi M, Gillevet PM. Long-term outcomes of fecal microbiota transplantation in patients with cirrhosis. Gastroenterology. 2019;156:1921\u20133. e1923.","journal-title":"Gastroenterology"},{"key":"7407_CR106","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41574-022-00794-0","volume":"19","author":"M Van Hul","year":"2023","unstructured":"Van Hul M, Cani PD. The gut microbiota in obesity and weight management: microbes as friends or foe? Nat Rev Endocrinol. 2023;19:258\u201371.","journal-title":"Nat Rev Endocrinol"},{"key":"7407_CR107","doi-asserted-by":"publisher","first-page":"590370","DOI":"10.3389\/fmicb.2020.590370","volume":"11","author":"M Napolitano","year":"2020","unstructured":"Napolitano M, Covasa M. Microbiota transplant in the treatment of obesity and diabetes: current and future perspectives. Front Microbiol. 2020;11:590370.","journal-title":"Front Microbiol"},{"key":"7407_CR108","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","volume":"20","author":"H Tilg","year":"2020","unstructured":"Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20:40\u201354.","journal-title":"Nat Rev Immunol"},{"key":"7407_CR109","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tem.2015.07.002","volume":"26","author":"M Rosenbaum","year":"2015","unstructured":"Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab. 2015;26:493\u2013501.","journal-title":"Trends Endocrinol Metab"},{"key":"7407_CR110","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41591-021-01399-2","volume":"27","author":"V Mocanu","year":"2021","unstructured":"Mocanu V, Zhang Z, Deehan EC, Kao DH, Hotte N, Karmali S, Birch DW, Samarasinghe KK, Walter J, Madsen KL. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial. Nat Med. 2021;27:1272\u20139.","journal-title":"Nat Med"},{"key":"7407_CR111","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2020.08.041","volume":"160","author":"E Rinott","year":"2021","unstructured":"Rinott E, Youngster I, Yaskolka Meir A, Tsaban G, Zelicha H, Kaplan A, Knights D, Tuohy K, Fava F, Scholz MU, et al. Effects of Diet-Modulated autologous fecal microbiota transplantation on weight regain. Gastroenterology. 2021;160:158\u2013e173110.","journal-title":"Gastroenterology"},{"key":"7407_CR112","doi-asserted-by":"publisher","first-page":"e1003051","DOI":"10.1371\/journal.pmed.1003051","volume":"17","author":"EW Yu","year":"2020","unstructured":"Yu EW, Gao L, Stastka P, Cheney MC, Mahabamunuge J, Torres Soto M, Ford CB, Bryant JA, Henn MR, Hohmann EL. Fecal microbiota transplantation for the improvement of metabolism in obesity: the FMT-TRIM double-blind placebo-controlled pilot trial. PLoS Med. 2020;17:e1003051.","journal-title":"PLoS Med"},{"key":"7407_CR113","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cgh.2019.07.006","volume":"18","author":"JR Allegretti","year":"2020","unstructured":"Allegretti JR, Kassam Z, Mullish BH, Chiang A, Carrellas M, Hurtado J, Marchesi JR, McDonald JAK, Pechlivanis A, Barker GF, et al. Effects of fecal microbiota transplantation with oral capsules in obese patients. Clin Gastroenterol Hepatol. 2020;18:855\u2013e863852.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7407_CR114","doi-asserted-by":"publisher","first-page":"e2030415","DOI":"10.1001\/jamanetworkopen.2020.30415","volume":"3","author":"KSW Leong","year":"2020","unstructured":"Leong KSW, Jayasinghe TN, Wilson BC, Derraik JGB, Albert BB, Chiavaroli V, Svirskis DM, Beck KL, Conlon CA, Jiang Y, et al. Effects of fecal Microbiome transfer in adolescents with obesity: the gut Bugs randomized controlled trial. JAMA Netw Open. 2020;3:e2030415.","journal-title":"JAMA Netw Open"},{"key":"7407_CR115","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40168-021-01060-7","volume":"9","author":"BC Wilson","year":"2021","unstructured":"Wilson BC, Vatanen T, Jayasinghe TN, Leong KSW, Derraik JGB, Albert BB, Chiavaroli V, Svirskis DM, Beck KL, Conlon CA, et al. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity. Microbiome. 2021;9:107.","journal-title":"Microbiome"},{"key":"7407_CR116","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-0716-2716-7_4","volume":"2575","author":"BF Botelho","year":"2023","unstructured":"Botelho BF, Barreira AL, Leite M Jr., Morales MM. Chronic kidney disease: challenges in translational medicine. Methods Mol Biol. 2023;2575:61\u201375.","journal-title":"Methods Mol Biol"},{"key":"7407_CR117","doi-asserted-by":"crossref","unstructured":"Bian J, Liebert A, Bicknell B, Chen XM, Huang C, Pollock CA. Faecal microbiota transplantation and chronic kidney disease. Nutrients. 2022:14.","DOI":"10.3390\/nu14122528"},{"key":"7407_CR118","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1042\/CS20171107","volume":"132","author":"WL Lau","year":"2018","unstructured":"Lau WL, Savoj J, Nakata MB, Vaziri ND. Altered Microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. Clin Sci (Lond). 2018;132:509\u201322.","journal-title":"Clin Sci (Lond)"},{"key":"7407_CR119","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/0886022X.2020.1864404","volume":"43","author":"J Zhao","year":"2021","unstructured":"Zhao J, Ning X, Liu B, Dong R, Bai M, Sun S. Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review. Ren Fail. 2021;43:102\u201312.","journal-title":"Ren Fail"},{"key":"7407_CR120","doi-asserted-by":"crossref","unstructured":"Arteaga-Muller GY, Flores-Trevi\u00f1o S, Bocanegra-Ibarias P, Robles-Espino D, Garza-Gonz\u00e1lez E, Fabela-Valdez GC, Camacho-Ortiz A. Changes in the progression of chronic kidney disease in patients undergoing fecal microbiota transplantation. Nutrients. 2024:16.","DOI":"10.3390\/nu16081109"},{"key":"7407_CR121","doi-asserted-by":"publisher","first-page":"1202850","DOI":"10.3389\/fimmu.2023.1202850","volume":"14","author":"K Yao","year":"2023","unstructured":"Yao K, Xie Y, Wang J, Lin Y, Chen X, Zhou T. Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus. Front Immunol. 2023;14:1202850.","journal-title":"Front Immunol"},{"key":"7407_CR122","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1042\/CS20180841","volume":"133","author":"Y Li","year":"2019","unstructured":"Li Y, Wang HF, Li X, Li HX, Zhang Q, Zhou HW, He Y, Li P, Fu C, Zhang XH, et al. Disordered intestinal microbes are associated with the activity of systemic lupus erythematosus. Clin Sci (Lond). 2019;133:821\u201338.","journal-title":"Clin Sci (Lond)"},{"key":"7407_CR123","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11926-021-00986-z","volume":"23","author":"R Li","year":"2021","unstructured":"Li R, Meng X, Chen B, Zhao L, Zhang X. Gut microbiota in lupus: a butterfly effect? Curr Rheumatol Rep. 2021;23:27.","journal-title":"Curr Rheumatol Rep"},{"key":"7407_CR124","doi-asserted-by":"publisher","first-page":"103541","DOI":"10.1016\/j.autrev.2024.103541","volume":"23","author":"I Seida","year":"2024","unstructured":"Seida I, Al Shawaf M, Mahroum N. Fecal microbiota transplantation in autoimmune diseases - An extensive paper on a pathogenetic therapy. Autoimmun Rev. 2024;23:103541.","journal-title":"Autoimmun Rev"},{"key":"7407_CR125","doi-asserted-by":"publisher","first-page":"102844","DOI":"10.1016\/j.jaut.2022.102844","volume":"130","author":"C Huang","year":"2022","unstructured":"Huang C, Yi P, Zhu M, Zhou W, Zhang B, Yi X, Long H, Zhang G, Wu H, Tsokos GC, et al. Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: an EXPLORER trial. J Autoimmun. 2022;130:102844.","journal-title":"J Autoimmun"},{"key":"7407_CR126","doi-asserted-by":"publisher","first-page":"339ra371","DOI":"10.1126\/scitranslmed.aaf2311","volume":"8","author":"Y Shono","year":"2016","unstructured":"Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016;8:339ra371.","journal-title":"Sci Transl Med"},{"key":"7407_CR127","doi-asserted-by":"publisher","first-page":"e29384","DOI":"10.1002\/pbc.29384","volume":"69","author":"CW Elgarten","year":"2022","unstructured":"Elgarten CW, Tanes C, Lee JJ, Danziger-Isakov LA, Grimley MS, Green M, Michaels MG, Barnum JL, Ardura MI, Auletta JJ, et al. Early stool Microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Pediatr Blood Cancer. 2022;69:e29384.","journal-title":"Pediatr Blood Cancer"},{"key":"7407_CR128","first-page":"135","volume":"28","author":"R Bansal","year":"2022","unstructured":"Bansal R, Park H, Taborda CC, Gordillo C, Mapara MY, Assal A, Uhlemann AC, Reshef R. Antibiotic Exposure, not Alloreactivity, is the major driver of Microbiome changes in hematopoietic cell transplantation. Transpl Cell Ther. 2022;28:135\u201344.","journal-title":"Transpl Cell Ther"},{"key":"7407_CR129","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40168-022-01270-7","volume":"10","author":"G Vaitkute","year":"2022","unstructured":"Vaitkute G, Panic G, Alber DG, Faizura-Yeop I, Cloutman-Green E, Swann J, Veys P, Standing JF, Klein N, Bajaj-Elliott M. Linking Gastrointestinal microbiota and metabolome dynamics to clinical outcomes in paediatric Haematopoietic stem cell transplantation. Microbiome. 2022;10:89.","journal-title":"Microbiome"},{"key":"7407_CR130","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1182\/bloodadvances.2018017731","volume":"2","author":"Z DeFilipp","year":"2018","unstructured":"DeFilipp Z, Peled JU, Li S, Mahabamunuge J, Dagher Z, Slingerland AE, Del Rio C, Valles B, Kempner ME, Smith M, et al. Third-party fecal microbiota transplantation following allo-HCT reconstitutes Microbiome diversity. Blood Adv. 2018;2:745\u201353.","journal-title":"Blood Adv"},{"key":"7407_CR131","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.3324\/haematol.2016.154351","volume":"102","author":"W Spindelboeck","year":"2017","unstructured":"Spindelboeck W, Schulz E, Uhl B, Kashofer K, Aigelsreiter A, Zinke-Cerwenka W, Mulabecirovic A, Kump PK, Halwachs B, Gorkiewicz G, et al. Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory Gastrointestinal graft-versus-host-disease. Haematologica. 2017;102:e210\u20133.","journal-title":"Haematologica"},{"key":"7407_CR132","doi-asserted-by":"crossref","unstructured":"van Lier YF, Davids M, Haverkate NJE, de Groot PF, Donker ML, Meijer E, Heubel-Moenen F, Nur E, Zeerleder SS, Nieuwdorp M et al. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients. Sci Transl Med 2020:12.","DOI":"10.1126\/scitranslmed.aaz8926"},{"key":"7407_CR133","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1200\/JCO.22.02366","volume":"41","author":"A Rashidi","year":"2023","unstructured":"Rashidi A, Ebadi M, Rehman TU, Elhusseini H, Kazadi D, Halaweish H, Khan MH, Hoeschen A, Cao Q, Luo X, et al. Randomized Double-Blind phase II trial of fecal microbiota transplantation versus placebo in allogeneic hematopoietic cell transplantation and AML. J Clin Oncol. 2023;41:5306\u201319.","journal-title":"J Clin Oncol"},{"key":"7407_CR134","doi-asserted-by":"crossref","unstructured":"Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The Microbiome and human cancer. Science 2021:371.","DOI":"10.1126\/science.abc4552"},{"key":"7407_CR135","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","volume":"28","author":"EM Park","year":"2022","unstructured":"Park EM, Chelvanambi M, Bhutiani N, Kroemer G, Zitvogel L, Wargo JA. Targeting the gut and tumor microbiota in cancer. Nat Med. 2022;28:690\u2013703.","journal-title":"Nat Med"},{"key":"7407_CR136","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1053\/j.gastro.2021.08.041","volume":"162","author":"J Yang","year":"2022","unstructured":"Yang J, Wei H, Zhou Y, Szeto CH, Li C, Lin Y, Coker OO, Lau HCH, Chan AWH, Sung JJY, Yu J. High-Fat diet promotes colorectal tumorigenesis through modulating gut microbiota and metabolites. Gastroenterology. 2022;162:135\u2013e149132.","journal-title":"Gastroenterology"},{"key":"7407_CR137","unstructured":"Phelps CM, Willis NB, Duan T, Lee AH, Zhang Y, Rodriguez JD, Pandey SP, Laughlin CR, Rosen ABI, McPherson AC et al. Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy. Cell. 2025."},{"key":"7407_CR138","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41591-022-01695-5","volume":"28","author":"KA Lee","year":"2022","unstructured":"Lee KA, Thomas AM, Bolte LA, Bj\u00f6rk JR, de Ruijter LK, Armanini F, Asnicar F, Blanco-Miguez A, Board R, Calbet-Llopart N, et al. Cross-cohort gut Microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Nat Med. 2022;28:535\u201344.","journal-title":"Nat Med"},{"key":"7407_CR139","doi-asserted-by":"publisher","first-page":"104967","DOI":"10.1016\/j.ebiom.2024.104967","volume":"100","author":"Y Yang","year":"2024","unstructured":"Yang Y, An Y, Dong Y, Chu Q, Wei J, Wang B, Cao H. Fecal microbiota transplantation: no longer Cinderella in tumour immunotherapy. EBioMedicine. 2024;100:104967.","journal-title":"EBioMedicine"},{"key":"7407_CR140","doi-asserted-by":"publisher","first-page":"e2413197","DOI":"10.1002\/advs.202413197","volume":"12","author":"S Hou","year":"2025","unstructured":"Hou S, Yu J, Li Y, Zhao D, Zhang Z. Advances in fecal microbiota transplantation for gut Dysbiosis-Related diseases. Adv Sci (Weinh). 2025;12:e2413197.","journal-title":"Adv Sci (Weinh)"},{"key":"7407_CR141","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/cid\/ciaf032","volume":"80","author":"Correction to","year":"2025","unstructured":"Correction to. A randomized controlled trial of efficacy and safety of fecal microbiota transplant for preventing recurrent clostridioides difficile infection. Clin Infect Dis. 2025;80:242\u20133.","journal-title":"Clin Infect Dis"},{"key":"7407_CR142","doi-asserted-by":"crossref","unstructured":"Cammarota G, Ianiro G, Kelly CR, Mullish BH, Allegretti JR, Kassam Z, Putignani L, Fischer M, Keller JJ, Costello SP et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut. 2019;68:2111\u20132121.","DOI":"10.1136\/gutjnl-2019-319548"},{"key":"7407_CR143","doi-asserted-by":"publisher","first-page":"1606417","DOI":"10.3389\/fcimb.2025.1606417","volume":"15","author":"YM Zheng","year":"2025","unstructured":"Zheng YM, Ye MM, Zhang HY, Luo DP, Liu T, He XX, Chen XY, Wu LH. Retrospective review: single- and multidonor washed microbiota transplantation have equivalent efficacy in the treatment of autism. Front Cell Infect Microbiol. 2025;15:1606417.","journal-title":"Front Cell Infect Microbiol"},{"key":"7407_CR144","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1053\/j.gastro.2024.01.008","volume":"166","author":"AF Peery","year":"2024","unstructured":"Peery AF, Kelly CR, Kao D, Vaughn BP, Lebwohl B, Singh S, Imdad A, Altayar O. AGA clinical practice guideline on fecal Microbiota-Based therapies for select Gastrointestinal diseases. Gastroenterology. 2024;166:409\u201334.","journal-title":"Gastroenterology"},{"key":"7407_CR145","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1038\/s41467-022-29672-z","volume":"13","author":"J Pan","year":"2022","unstructured":"Pan J, Gong G, Wang Q, Shang J, He Y, Catania C, Birnbaum D, Li Y, Jia Z, Zhang Y, et al. A single-cell Nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea. Nat Commun. 2022;13:2117.","journal-title":"Nat Commun"},{"key":"7407_CR146","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrgastro.2016.98","volume":"13","author":"A Khoruts","year":"2016","unstructured":"Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol. 2016;13:508\u201316.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7407_CR147","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1126\/science.aad8852","volume":"352","author":"SS Li","year":"2016","unstructured":"Li SS, Zhu A, Benes V, Costea PI, Hercog R, Hildebrand F, Huerta-Cepas J, Nieuwdorp M, Saloj\u00e4rvi J, Voigt AY, et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science. 2016;352:586\u20139.","journal-title":"Science"},{"key":"7407_CR148","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature13828","volume":"517","author":"CG Buffie","year":"2015","unstructured":"Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, et al. Precision Microbiome reconstitution restores bile acid mediated resistance to clostridium difficile. Nature. 2015;517:205\u20138.","journal-title":"Nature"},{"key":"7407_CR149","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrmicro.2017.44","volume":"15","author":"L Zitvogel","year":"2017","unstructured":"Zitvogel L, Daill\u00e8re R, Roberti MP, Routy B, Kroemer G. Anticancer effects of the Microbiome and its products. Nat Rev Microbiol. 2017;15:465\u201378.","journal-title":"Nat Rev Microbiol"},{"key":"7407_CR150","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1021\/acs.accounts.6b00087","volume":"49","author":"JH Park","year":"2016","unstructured":"Park JH, Hong D, Lee J, Choi IS. Cell-in-Shell hybrids: chemical nanoencapsulation of individual cells. Acc Chem Res. 2016;49:792\u2013800.","journal-title":"Acc Chem Res"},{"key":"7407_CR151","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.mattod.2023.01.001","volume":"62","author":"H Luo","year":"2023","unstructured":"Luo H, Wu F, Wang X, Lin S, Zhang M, Cao Z, Liu J. Encoding bacterial colonization and therapeutic modality by wrapping with an adhesive drug-loadable Nanocoating. Mater Today. 2023;62:98\u2013110.","journal-title":"Mater Today"},{"key":"7407_CR152","doi-asserted-by":"publisher","first-page":"7808","DOI":"10.1038\/s41467-022-35579-6","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo H, Chen Y, Kuang X, Wang X, Yang F, Cao Z, Wang L, Lin S, Wu F, Liu J. Chemical reaction-mediated covalent localization of bacteria. Nat Commun. 2022;13:7808.","journal-title":"Nat Commun"},{"key":"7407_CR153","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Li M, Chen Q, Li X, Chen L, Dong Z, Zhu W, Yang Y, Liu Z, Chen Q. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun. 2022;13:3432.","journal-title":"Nat Commun"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07407-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T16:02:15Z","timestamp":1764691335000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07407-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7407"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07407-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that there are no interest conflicts and agree to publish this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1370"}}